Molecular markers of various stages of non-small-cell lung cancer

被引:2
|
作者
Zborovskaya, IB [1 ]
Tatosyan, AG [1 ]
机构
[1] Russian Acad Med Sci, Inst Carcinogenesis, Blokhin Canc Res Ctr, Moscow 115478, Russia
关键词
non-small-cell lung cancer; molecular markers; predisposition; early diagnostics; prognosis;
D O I
10.1023/B:MBIL.0000023729.73314.84
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Studies performed in the recent decade in the Laboratory of the Regulation of Cell and Virus Oncogenes associated structural and functional defects of several oncogenes and tumor suppressor genes with various stages of non-small-cell lung cancer. High risk of lung cancer was established for carriers of rare alleles of the Hras1 minisatellite, the hypermethylated p16(INK4A) promoter, and microsatellite defects in chromosome regions 3p12, 3p14.2, 3p22-24, 3p21, 3p25, 9p21, and 17p13. Analysis of the HrasI minisatellite and microsatellites located in two minimal deletion overlap regions of 1p36 was shown to allow a more reliable prognosis in lung cancer. The results testified again that panels of molecular markers are useful for individual risk assessment, early and differential diagnosis, and prognosis in cancer.
引用
收藏
页码:155 / 164
页数:10
相关论文
共 50 条
  • [31] MOLECULAR AND PATHOLOGICAL MARKERS IN STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG
    STRAUSS, GM
    KWIATKOWSKI, DJ
    HARPOLE, DH
    LYNCH, TJ
    SKARIN, AT
    SUGARBAKER, DJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1265 - 1279
  • [32] Predictive molecular markers in non-small cell lung cancer
    Rosell, R
    Tarón, M
    O'Brate, A
    [J]. CURRENT OPINION IN ONCOLOGY, 2001, 13 (02) : 101 - 109
  • [33] Advanced Non-Small-Cell Lung Cancer
    Sohal, Sukhwinder S.
    Walters, Eugene H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1998 - 1999
  • [34] Immunotherapy of non-small-cell lung cancer
    Reinmuth, Niels
    Merk, Martina
    Duell, Thomas
    [J]. ONKOLOGE, 2021, 27 (02): : 179 - 190
  • [35] Encephalitis in non-small-cell lung cancer
    Costa e Silva, M.
    Silva, E.
    Mendes, A.
    Barroso, A.
    [J]. PULMONOLOGY, 2021, 27 (06): : 582 - 583
  • [36] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 996 - 997
  • [37] Prognostic molecular markers in non-small cell lung cancer
    Niklinski, J
    Niklinska, W
    Laudanski, J
    Chyczewska, E
    Chyczewski, L
    [J]. LUNG CANCER, 2001, 34 : S53 - S58
  • [38] MOLECULAR MARKERS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Heigener, D.
    [J]. ANTICANCER RESEARCH, 2011, 31 (05) : 1979 - 1979
  • [39] Treatment of advanced (stages III and IV) non-small-cell lung cancer - Foreword
    Williams, SD
    [J]. CURRENT PROBLEMS IN CANCER, 1998, 22 (02) : 85 - 85
  • [40] Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways
    Borczuk, AC
    Gorenstein, L
    Walter, KL
    Assaad, AA
    Wang, LQ
    Powell, CA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05): : 1949 - 1960